Clinical Trial: The Safety and Tolerability of STSA-1002 Following Subcutaneous Injection in Healthy Subjects
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Antineutrophil Cytoplasmic Antibody Associated Vasculitis
Study Type: INTERVENTIONAL
Official Title: An Open-label, Single-ascending Dose, Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of STSA-1002 Subcutaneous Injection in Healthy Subjects
Brief Summary:
An Open-label, Single-ascending dose, Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of STSA-1002 Subcutaneous Injection in Healthy Subjects
Read more